A first study showed that colorectal tumors exhibited enhanced PI3K activity compared with normal colonic mucosa, raising the possibility that PI3K may be a potential target for new strategies for the treatment of colorectal carcinoma [313]. Here, PIK3CD is linked to colorectal neoplasm.